RISK BASED INSPECTION [SCHEDULE M-POINT (13.1)]
![RISK BASED INSPECTION [SCHEDULE M-POINT (13.1)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-13.1-768x1086.jpg)
In a risk-based inspection (RBI), Schedule M point 13.1 is assessed as a mix-up prevention control because incorrect status identification of containers/equipment can lead to wrong material use, cross-batch contamination, and release of unapproved product. What 13.1 requires: All containers…





![RISK BASED INSPECTION [WHO TRS 986-POINT (12.6-12.10)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-12.6-12.10-768x1086.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (12.4-12.5)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-12.4-12.5-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M & WHO TRS 986-POINT (12.1-12.3)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-WHO-TRS-986-12.1-12.3-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.16-11.20)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.16-11.20-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.14-11.15)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.14-11.15-768x1086.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.13)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.13-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (11.12)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.12-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.11)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.11-768x1086.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (11.9-11.10)]](https://pharmadevils.com/wp-content/uploads/2024/10/WHO-TRS-986-11.9-11.10-768x1086.jpg)